SCHEMBL17803687

SCHEMBL17803687

c1ccc(OC(CNc2ncnc3ccccc23)c2ccccc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A3 Q01959 2/20 0.56
▸ EGFR P00533 6/20 0.52
▸ NR2F2 P24468 4/20 0.52
▸ GALR3 O60755 3/20 0.52
▸ RAB9A P51151 3/20 0.52
▸ SMN1; SMN2 Q16637 6/20 0.51
▸ LMNA P02545 4/20 0.51
▸ HTT P42858 3/20 0.51
▸ MAPK1 P28482 2/20 0.51
▸ TSHR P16473 1/20 0.51
▸ APP P05067 1/20 0.50
▸ LDHA P00338 1/20 0.49
▸ POLB P06746 1/20 0.48
▸ KDR P35968 1/20 0.48
▸ TEK Q02763 1/20 0.48
▸ MAPT P10636 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ GAA P10253 3/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ NPC1 O15118 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11249827 0.83 GBA1 (0.57) EGFRNR2F2GALR3RAB9ASMN1; SMN2
SCHEMBL17803692 0.82 EGFR (0.62) EGFRNR2F2GALR3RAB9ASMN1; SMN2
SCHEMBL11252740 0.81 EGFR (0.51) EGFRNR2F2GALR3RAB9ASMN1; SMN2
SCHEMBL17799808 0.81 SLC6A3 (0.61) SLC6A3RAB9ASMN1; SMN2HTTAPP
SCHEMBL17803701 0.78 NR2F2 (0.62) EGFRNR2F2GALR3RAB9ASMN1; SMN2
SCHEMBL11260225 0.76 GBA1 (0.55) EGFRNR2F2GALR3RAB9ASMN1; SMN2
SCHEMBL17803682 0.76 EGFR (0.55) SLC6A3EGFRNR2F2GALR3RAB9A
SCHEMBL17803686 0.76 NR2F2 (0.59) EGFRNR2F2GALR3RAB9ASMN1; SMN2
SCHEMBL11258725 0.74 RAB9A (0.54) EGFRNR2F2GALR3RAB9ASMN1; SMN2
SCHEMBL16259077 0.74 EGFR (0.59) EGFRNR2F2GALR3RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3226867-A1 HETEROCYCLIC COMPOUNDS AS BIOGENIC AMINE TRANSPORT MODULATORS Ananthan, Subramaniam (US) 2017-10-11 — — EP disclosed
WO-2016090296-A1 HETEROCYCLIC COMPOUNDS AS BIOGENIC AMINE TRANSPORT MODULATORS ANANTHAN SUBRAMANIAM (US) 2016-06-09 — — WO disclosed
Send feedback